Perry W, Viglione D J
Department of Psychiatry, University of California, San Diego, La Jolla 92093.
J Pers Assess. 1991 Jun;56(3):487-501. doi: 10.1207/s15327752jpa5603_10.
The standard model of assessing ego impairment relies on patients' accurate self-report and description of their behavior. This study offers an alternative approach to assessing ego impairment in a population of major depression, melancholic type outpatients treated with tricyclic antidepressants. A new index called the Ego Impairment Index (EII) was developed. The index is derived from the Rorschach test and offers a single composite score of ego impairment. It was hypothesized that those melancholic, biologically depressed individuals who were lacking in ego resources were less likely to benefit from tricyclic antidepressant treatment. Thus, the EII could predict overall outcome while on antidepressants. The results support that the level of ego impairment, as assessed by the EII, could predict depression outcome averaged over 9 weeks of tricyclic antidepressant treatment.
评估自我功能损害的标准模式依赖于患者对自身行为的准确自我报告和描述。本研究提供了一种替代方法，用于评估接受三环类抗抑郁药治疗的重度抑郁、 melancholic型门诊患者群体中的自我功能损害情况。开发了一种名为自我功能损害指数（EII）的新指标。该指数源自罗夏墨迹测验，提供了一个自我功能损害的单一综合评分。研究假设，那些缺乏自我资源的 melancholic型、生物学上抑郁的个体从三环类抗抑郁药治疗中获益的可能性较小。因此，EII可以预测接受抗抑郁药治疗期间的总体结果。结果支持，通过EII评估的自我功能损害水平可以预测三环类抗抑郁药治疗9周期间的平均抑郁结果。
